BOLTON SECURITIES CORPORATION’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,000
Closed -$232K – 2353
2026
Q2
$232K Buy
+5,000
New +$180K 0.01% 856

Other funds holding ASTH

BOLTON SECURITIES CORPORATION's ASTH Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION sold out of Astrana Health (ASTH) in Q3 2026, closing a stake of 5,000 shares — an estimated $232K sold.

BOLTON SECURITIES CORPORATION first reported a position in ASTH in Q2 2026 and held it in 1 quarter. The position peaked at $232K in Q2 2026. 129 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • BOLTON SECURITIES CORPORATION reported no remaining Astrana Health position as of Q3 2026 after selling out during the quarter.
  • BOLTON SECURITIES CORPORATION sold 5,000 Astrana Health shares in Q3 2026, an estimated $232K.
  • BOLTON SECURITIES CORPORATION first reported a position in Astrana Health in Q2 2026 and held it in 1 quarter.
  • BOLTON SECURITIES CORPORATION's Astrana Health position peaked at $232K in Q2 2026.
  • 129 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.